http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Ruth Barraclough ) 국제비교한국학회 2011 비교한국학 Comparative Korean Studies Vol.19 No.3
This article examines the factory girl classic The Solitary Room (published in 1995) as part of an archive of Korean industrial literature. The Solitary Room fixes on adolescent sexuality and suicide to tell the story of individual factory girls who lived through rapid industrialisation of the late 1970s. This article argues that The Solitary Room grapples with the elusive subject of ``factory girl`` at the same time that it addresses the guilt and grief of post-industrial South Korean society over the recent trauma of industrialisation. The story displays a fear of both revolution and class immobility, and part of its success as a best-seller can be related to the conventionality of its narrative. Yet The Solitary Room is exceptional for signaling the complicity of readers (society) in the violence done to factory girls. The article concludes by arguing that The Solitary Room should be read as part of a distinct oeuvre of factory girl literature.
James Chin-Hsin Yang,안명주,Kazuhiko Nakagawa,Tomohide Tamura,Helen Barraclough,Sotaro Enatsu,Rebecca Cheng,Mauro Orlando 대한암학회 2015 Cancer Research and Treatment Vol.47 No.3
Purpose A recent phase III study (PARAMOUNT) demonstrated that pemetrexed continuation maintenance therapy is a new treatment paradigm for advanced nonsquamous non-small cell lung cancer (NSCLC). The majority of patients enrolled in PARAMOUNT were Caucasian (94%). We reviewed efficacy and safety data from two clinical trials, which enrolled East Asian (EA) patients, to supplement data from PARAMOUNT on pemetrexed continuation maintenance therapy in patients with nonsquamous NSCLC. Materials and Methods Study S110 was a phase II, multicenter, randomized, controlled, open-label trial in never-smoker, chemonaïve, EA patients (n=31) with locally advanced or metastatic nonsquamous NSCLC (n=27). Study JMII was a multicenter, open-label, single-arm, postmarketing, clinical trial in Japanese patients (n=109) with advanced nonsquamous NSCLC. PARAMOUNT was a multicenter, randomized, double-blind, placebo-controlled trial in patients with advanced nonsquamous NSCLC. Results In EA patients with nonsquamous NSCLC, the median progression-free survival (PFS) for pemetrexed continuation maintenance therapy was 4.04 months (95% confidence interval [CI], 3.22 to 5.29 months) in study S110 and 3.9 months (95% CI, 3.2 to 5.2 months) in study JMII. The median PFS for pemetrexed continuation maintenance therapy in PARAMOUNT was 4.1 months (95% CI, 3.2 to 4.6 months). Pemetrexed continuation maintenance therapy in EA patients in studies S110 and JMII did not lead to any unexpected safety events, and was consistent with PARAMOUNT’s safety profile. Conclusion The efficacy and safety data in the EA trials were similar to those in PARAMOUNT despite differences in patient populations and study designs. These data represent consistent evidence for pemetrexed continuation maintenance therapy in EA patients with advanced nonsquamous NSCLC.
Elliott, Paul ,R.,Irvine, Andrew ,F.,Jung, Hyun ,Suk,Tozawa, Kaeko,Pastok, Martyna ,W.,Picone, Remigio,Badyal, Sandip ,K.,Basran, Jaswir,Rudland, Philip ,S.,Barraclough, Roger Cell Press 2012 Structure Vol.20 No.4
<P><B>Summary</B></P><P>Filament assembly of nonmuscle myosin IIA (NMIIA) is selectively regulated by the small Ca<SUP>2+</SUP>-binding protein, S100A4, which causes enhanced cell migration and metastasis in certain cancers. Our NMR structure shows that an S100A4 dimer binds to a single myosin heavy chain in an asymmetrical configuration. NMIIA in the complex forms a continuous helix that stretches across the surface of S100A4 and engages the Ca<SUP>2+</SUP>-dependent binding sites of each subunit in the dimer. Synergy between these sites leads to a very tight association (K<SUB>D</SUB> ∼1 nM) that is unique in the S100 family. Single-residue mutations that remove this synergy weaken binding and ameliorate the effects of S100A4 on NMIIA filament assembly and cell spreading in A431 human epithelial carcinoma cells. We propose a model for NMIIA filament disassembly by S100A4 in which initial binding to the unstructured NMIIA tail initiates unzipping of the coiled coil and disruption of filament packing.</P>